Tuberculosis retreatment ‘others’ in comparison with classical retreatment cases; a retrospective cohort review

BMC Public Health

Table 2 Prevalence of HIV by patient characteristics, retreatment type among retreatment TB patients with known HIV test results at eleven RRHs, Uganda (n = 690)

Characteristic	Total		Classical retreatment cases		‘Others’ retreatment cases		P-value*
		HIV Positive		HIV Positive		HIV Positive
		n (%)		n (%)		n (%)
Overall	690	424^b (61.4)	374	200 (53.5)	316	224 (70.9)	<0.001**
Sex
Male	492	284 (57.8)	289	145 (50.2)	203	139 (68.5)	0.022
Female	198	140 (70.7)	85	55 (64.7)	113	85 (75.2)
Age group, years^a
<15	35	24 (68.6)	3	2 (66.7)	32	22 (68.8)	<0.001
15-44	488	316 (64.8)	277	157 (56.7)	211	159 (75.4)
>44	166	83 (50.0)	94	40 (42.6)	73	43 (58.9)
Anatomical site
Pulmonary	650	391 (60.2)	374	200 (53.5)	276	191 (69.2)	<0.001
Extrapulmonary	40	33 (82.5)	0	0 (0.0)	40	33 (82.5)
Treatment regimen
Retreatment: 2SRHZE/1RHZE/5RHE	553	329 (59.5)	357	192 (53.8)	196	137 (69.9)	<0.001
New:2RHZE/6EH or 2RHZ/4RH	106	73 (68.9)	16	8 (50.0)	90	65 (72.2)
Other regimen	31	22 (71.0)	1	0 (0.0)	30	22 (73.3)

*P-values are from either Pearson’s chi-squared test of Fischer’s exact tests for the difference between given characteristics and the type of retreatment among only HIV positive patients
**P-value from Z-test for two proportions
^a1 patient had missing data on this variable
^bCotrimoxazole preventive therapy and antiretroviral treatment were documented among 385 (91 %) and 221 (52 %) of all HIV positive TB retreatment patients respectively

ISSN: 1471-2458